Recent Neuroblastoma News

Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s... Continue Reading

Survivors of Childhood Cancer Face Risk of More Cancer (July 11, 2011)

Children who survive cancer have an increased risk of developing cancer later in life. These findings were recently reported in the Journal of Clinical Oncology. The good news about childhood cancer is... Continue Reading

New Substances Added to List of Cancer-Causing Agents (June 21, 2011)

In the most recent version of the National Toxicology Program’s Report on Carcinogens, two new substances have been classified as “known human carcinogens” and six others have been classified as... Continue Reading

Medical Costs Higher Among Survivors (June 21, 2011)

Cancer survivors tend to pay substantially more in annual medical costs compared with people who have never had cancer. These findings were recently reported in Cancer. A significant number of adults in... Continue Reading

Improved Survival with Busulphan-Melphalan Chemotherapy in Pediatric Neuroblastoma (June 8, 2011)

Treatment with high doses of the chemotherapy combination including busulphan and melphalan significantly improves survival and reduces cancer progression among pediatric patients with high-risk neuroblastoma.... Continue Reading

Fewer Lung Cancer Deaths Among Women (April 11, 2011)

The lung cancer death rate among women appears to be declining for the first time in 40 years, according to an annual report published by multiple institutions. Findings from the report were recently released... Continue Reading

Cancer Care Costs Expected to Rise by at Least 27% Over Next Decade (January 18, 2011)

As a result of the growth and aging of the US population, cancer care costs are expected to rise by 27% by the year 2020. This estimate does not include increases in the cost of cancer treatment itself,... Continue Reading

Reduced Chemotherapy Regimen May Be Effective in Neuroblastoma (November 10, 2010)

According to results of a Phase III clinical trial, patients with intermediate-risk neuroblastoma may be effectively treated with reduced doses of chemotherapy given over a shorter period. These findings... Continue Reading

Hycamtin/Cyclophosphamide Delays Progression of Recurrent Neuroblastoma (September 13, 2010)

Children with recurrent or refractory neuroblastoma experienced an improvement in progression-free survival when treated with the combination of Hycamtin® (topotecan) plus cyclophosphamide; overall survival,... Continue Reading

Neuroblastoma Survival has Improved (May 12, 2010)

Between 1979 and 2005, ten-year overall survival with neuroblastoma improved from 34.9% to 65%. The results of this study, conducted in Italy, were published in the Journal of Clinical Oncology. Neuroblastoma... Continue Reading

« Previous PageNext Page »